Inhibition of Chikungunya Virus Infection by 4-Hydroxy-1-Methyl-3-(3-morpholinopropanoyl)quinoline-2(1

Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
13 Apr 2021
Historique:
received: 25 01 2021
accepted: 23 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 20 4 2021
Statut: epublish

Résumé

The re-emergence of Chikungunya virus (CHIKV) infection in humans with no approved antiviral therapies or vaccines is one of the major problems with global significance. In the present investigation, we screened 80 in-house quinoline derivatives for their anti-CHIKV activity by computational techniques and found 4-hydroxy-1-methyl-3-(3-morpholinopropanoyl)quinoline-2(1

Identifiants

DOI: 10.1021/acsomega.1c00447 PMID: 33869959 PMC: PMC8047676
pubmed: 33869959
doi: 10.1021/acsomega.1c00447
pmc: PMC8047676
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9791-9803

Informations de copyright

© 2021 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):447-51
pubmed: 11944696
S Afr Med J. 1984 Aug 11;66(6):217-8
pubmed: 6087474
Microbiol Rev. 1994 Sep;58(3):491-562
pubmed: 7968923
J Gen Virol. 1969 Mar;4(2):203-14
pubmed: 4306296
Antiviral Res. 2014 Jun;106:125-34
pubmed: 24680954
Nature. 2010 Dec 2;468(7324):705-8
pubmed: 21124457
J Med Chem. 2006 Mar 23;49(6):2127-37
pubmed: 16539402
Arch Gesamte Virusforsch. 1972;36(1):93-104
pubmed: 4335025
J Mol Model. 2012 Jan;18(1):39-51
pubmed: 21445710
Antiviral Res. 2013 Apr;98(1):12-8
pubmed: 23380636
Int J Mol Sci. 2016 Aug 24;17(9):
pubmed: 27563890
PLoS Pathog. 2019 Jan 22;15(1):e1007239
pubmed: 30668592
Virology. 1990 Feb;174(2):450-8
pubmed: 2154882
J Biol Chem. 2008 Aug 8;283(32):21899-908
pubmed: 18559340
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Infect Disord Drug Targets. 2009 Apr;9(2):101-4
pubmed: 19275698
J Med Chem. 2014 Mar 13;57(5):1914-31
pubmed: 24195700
Biochem Pharmacol. 2016 Nov 15;120:15-21
pubmed: 27664855
PLoS One. 2014 Jun 24;9(6):e100531
pubmed: 24959709
Int J Antimicrob Agents. 2018 Nov;52(5):622-628
pubmed: 30063998
J Virol. 1981 Mar;37(3):1060-5
pubmed: 6262524
Sci Rep. 2016 Apr 13;6:24027
pubmed: 27071308
ACS Med Chem Lett. 2016 Apr 20;7(6):558-62
pubmed: 27326326
Proteins. 2011 Oct;79(10):2794-812
pubmed: 21905107
J Gen Virol. 1982 Jan;58 Pt 1:47-61
pubmed: 7142969
Acta Biochim Pol. 2004;51(3):609-24
pubmed: 15448724
Trans R Soc Trop Med Hyg. 1955 Jan;49(1):28-32
pubmed: 14373834
Int J Antimicrob Agents. 2007 Oct;30(4):297-308
pubmed: 17629679
Nature. 2010 Dec 2;468(7324):709-12
pubmed: 21124458
Antiviral Res. 2012 Apr;94(1):18-24
pubmed: 22343093
J Virol Methods. 2014 Apr;199:86-94
pubmed: 24462973
J Clin Virol. 2015 Mar;64:144-52
pubmed: 25453326
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
J Med Chem. 2014 Feb 27;57(4):1147-66
pubmed: 24079775
Biomed Pharmacother. 2008 Sep;62(7):430-5
pubmed: 17587535
Eur J Med Chem. 2017 Feb 15;127:334-340
pubmed: 28068604
J Pharm Sci. 1968 May;57(5):715-33
pubmed: 4873686
N Engl J Med. 2015 Jul 2;373(1):94-5
pubmed: 26132956
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126881
pubmed: 31843348
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Antimicrob Agents Chemother. 2013 Jan;57(1):155-67
pubmed: 23275491
J Med Virol. 2010 May;82(5):817-24
pubmed: 20336760
J Virol. 1994 Sep;68(9):5781-91
pubmed: 8057460
J Virol. 1984 Dec;52(3):857-64
pubmed: 6492263
J Gen Virol. 2015 Sep;96(9):2483-2500
pubmed: 26219641
Antiviral Res. 2013 Jan;97(1):74-80
pubmed: 23127365
Mol Cell. 2000 Feb;5(2):255-66
pubmed: 10882067
Biochem Pharmacol. 2020 Apr;174:113777
pubmed: 31874146
Antimicrob Agents Chemother. 2010 Feb;54(2):871-81
pubmed: 19949061
Virol J. 2007 May 03;4:39
pubmed: 17477867
Cell. 2001 Apr 6;105(1):137-48
pubmed: 11301009
PLoS One. 2015 Jul 24;10(7):e0133511
pubmed: 26208101
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Clin Microbiol Rev. 2017 Dec 13;31(1):
pubmed: 29237708
J Virol. 2014 Nov;88(21):12180-92
pubmed: 25142598
Front Public Health. 2020 Dec 15;8:618624
pubmed: 33384981
WHO South East Asia J Public Health. 2014 Jan-Mar;3(1):22-26
pubmed: 28607250
Lancet Infect Dis. 2006 Feb;6(2):67-9
pubmed: 16439323
Virology. 1984 Feb;133(1):92-110
pubmed: 6322438

Auteurs

Mohammad Islamuddin (M)

Molecular Virology Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.
Laboratory of Sustainable Animal Environment, Graduate School of Agricultural Science, Tohoku University, Osaki, Miyagi 989-6711, Japan.

Obaid Afzal (O)

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.

Wajihul Hasan Khan (WH)

Kusuma School of Biological Sciences, Indian Institute of Technology (IIT), New Delhi 110016, India.

Malik Hisamuddin (M)

Molecular Virology Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.

Abdulmalik Saleh Alfawaz Altamimi (ASA)

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.

Ibraheem Husain (I)

Department of Pharmacology, School of Pharmaceutical and Research, Hamdard University, New Delhi 110062, India.

Kentaro Kato (K)

Laboratory of Sustainable Animal Environment, Graduate School of Agricultural Science, Tohoku University, Osaki, Miyagi 989-6711, Japan.

Mubarak A Alamri (MA)

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.

Shama Parveen (S)

Molecular Virology Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.

Classifications MeSH